Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
29 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sigma-Tau Pharmaceuticals, Inc (Sigma-Tau) a subsidiary of Sigma-Tau S.p.A. is a pharmaceutical company that discovers and develops novel medicines. The company offers products such as Cystaran, Carnitor, Matulane, Adagen, Abelcet, DepoCyt, ProXeed Plus, VSL and Colief products. It offers patient support, discovery and development of novel medicines for the unmet needs of patients with rare diseases. The company offers its forms of tablets, oral solution, sugar-free oral solution, capsules and injection. It sells its products through a network of distributors in the US and abroad. Sigma-Tau is headquartered in Gaithersburg, Maryland, the US

Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed

  
Source:
Document ID
GDPH189891D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sigma-Tau Pharmaceuticals, Inc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sigma-Tau Pharmaceuticals, Inc, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sigma-Tau Pharmaceuticals, Inc, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sigma-Tau Pharmaceuticals, Inc, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201682
Sigma-Tau Pharmaceuticals, Inc, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Sigma-Tau Pharmaceuticals, Inc, Pharmaceuticals &Healthcare, Deal Details1115
  Asset Purchase111
    Sigma-Tau Acquires Specialty Pharma Business From Enzon Pharma112
  Licensing Agreements131
    Sigma-Tau Pharma Enters into Licensing Agreement with Crosscare for Colief131
    Soligenix Terminates Licensing Agreement With Sigma-Tau Pharma For orBec141
    Soligenix Expands Licensing Agreement With Sigma-Tau Pharma For orBec152
    Gentium Enters Into Licensing Agreement With Sigma-Tau Pharma172
  Equity Offering191
    RegeneRx BioPharma Completes Registered Direct Offering Of US$1.45 Million192
    Soligenix Completes Private Placement Of Its Common Stock For US$6 Million212
  Asset Transactions231
    Jazz Pharma Acquires Defibrotide from Sigma-Tau Pharma for USD250 Million232
  Acquisition251
    Sigma-Tau May Sell Sigma-Tau Pharma251
Sigma-Tau Pharmaceuticals, Inc - Key Competitors261
Key Employees271
Locations And Subsidiaries281
  Head Office281
Appendix291
  Methodology291
  About GlobalData291
  Contact Us291
  Disclaimer291

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sigma-Tau-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6947>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sigma-Tau-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6947>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research